| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Infection and Immunity, June 2008, p. 2428-2438, Vol. 76, No. 6
0019-9567/08/$08.00+0 doi:10.1128/IAI.01128-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Oral Microbiology and Immunology,1 Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Republic of South Korea2
Received 13 August 2007/ Returned for modification 10 October 2007/ Accepted 28 March 2008
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The bacterial outer membrane (OM) provides a crucial contact barrier to host cells, and outer membrane proteins (OMPs) belong to the first class of molecules involved in host-bacterium interactions. They are involved in adhesion to and in the induction of cytopathic effects on host cells and in inflammatory and immunological responses. OMPs are valuable candidates with which to study host-pathogen interactions and to identify appropriate targets for therapy and prophylaxis. It is therefore important to identify common virulence determinants that are localized at the surfaces of oral spirochetes and to characterize them in order to elucidate their roles in periodontal pathogenesis. OMPs of oral spirochetes have been reported previously to participate in the colonization of the host, cytopathogenesis, and the inflammatory responses of the host in periodontitis (8, 18, 45). Most of the OMPs identified in oral spirochetes are species specific (5, 14, 18, 19, 33, 37, 45, 53).
Tp92 (837 amino acid [aa] residues), one of the surface antigens of T. pallidum, with a molecular mass of 92 kDa, has been reported previously to have opsonic potential and to induce a protective immune response to syphilis, a T. pallidum infection (7). This protein has been suggested for use as a syphilis serodiagnostic marker and has shown 98% sensitivity and 97% specificity when tested for this capacity (50). Tp92-related proteins are also found in other genera of spirochetes, like Borrelia burgdorferi and Leptospira interrogans, and they are distributed in a wide range of gram-negative bacteria, like Chlamydia trachomatis (Omp85 analog), Neisseria spp. (Omp85), Pasteurella multocida (Oma87), Haemophilus spp. (D15), and Helicobacter pylori (D15) (43). From a functional analysis, Omp85 proteins of Neisseria spp. appear to be essential for the viability of the bacteria and to be involved in the assembly of OMPs like porins PorA and PorB, secretin PilQ, and the siderophore receptors FrpB and RmpM (51), as well as in lipid transport to the OM (21). Immunization with D15 from Haemophilus spp. was shown previously to be protective against infection with Haemophilus in animal models, and D15 has been considered as a potential vaccine candidate (49), as has Tp92 from T. pallidum (7). Antisera against Oma87 of P. multocida and D15 of H. influenzae have been found previously to be immunoprotective in animal models (1, 36). Tp92/Omp85 homologs are therefore a family of highly conserved OMPs in gram-negative bacteria with possibly conserved functions.
Periodontitis is characterized by bone resorption, which leads to tooth loss. Osteoclasts and osteoblasts play important roles in bone resorption, and osteoblastic cells regulate the differentiation, fusion, and activation of osteoclasts. Osteoclasts are activated by the receptor activator of nuclear factor-
B (NF-
B) ligand (RANKL) that is stimulated from osteoblasts/stromal cells by osteoclastogenic factors such as parathyroid hormone, 1,25(OH)2 vitamin D3, interleukins (interleukin-1 [IL-1], IL-6, and IL-11), tumor necrosis factor alpha (TNF-
), and prostaglandin E2 (PGE2) (28, 31).
This study aimed at identifying and characterizing the Tp92 homologs of four representative oral spirochetes strongly associated with periodontitis. The tp92 gene homologs were identified either by the examination of the genome sequence (in the case of T. denticola) or by PCR amplification and sequencing, and the activities of the Tp92 homologs were assessed after the cloning of the tp92 gene homologs in Escherichia coli and the purification of the recombinant proteins. The amino acid sequences of the Tp92 homologs from the oral treponemes showed high levels of homology. The immuno-cross-reactivities and the surface exposure patterns of the Tp92 homologs in oral treponemes were demonstrated with a polyclonal antibody (Ab) raised against the Tp92 homolog of T. denticola. The Tp92 homologs were then shown to bind to epithelial cells and induce the expression of proinflammatory and osteoclastogenic factors in host cells like monocytes and fibroblasts.
| MATERIALS AND METHODS |
|---|
|
|
|---|
E. coli DH5
-T1 (Invitrogen, Carlsbad, CA) was used for TA cloning, and E. coli M15 (Qiagen, Valencia, CA) was used for the expression of the treponeme Tp92 homologs. E. coli bacteria containing the plasmids were cultured aerobically in Luria-Bertani broth supplemented with 50 µg of ampicillin/ml for the DH5
-T1 strain or with 100 µg of ampicillin/ml and 25 µg of kanamycin/ml for the M15 strain.
THP-1 cells (ATCC TIB-202), a human monocytic cell line, and primary cultured periodontal ligament (PDL) cells were prepared as described previously (9). THP-1 and PDL cells were cultured in RPMI 1640 medium and
-minimal essential medium supplemented with 10% fetal bovine serum (FBS), respectively, and used for stimulation with the recombinant Tp92 homologs. KB cells (ATCC CCL-17), an oral carcinoma epithelial cell line, were cultured in RPMI 1640 medium supplemented with 10% FBS and used for a bacterial binding assay. An NF-
B reporter cell line, CHO/CD14/TLR4, which expresses CD14 and Toll-like receptor 4 (TLR4) and has the CD25 reporter gene with the human E-selectin promoter, was kindly provided by S. H. Han and cultured as described previously (24). The CHO/CD14/TLR4 cells were cultured in Ham's F-12 medium (HyClone Laboratories, Logan, UT) supplemented with 10% FBS and were used to verify that prepared recombinant proteins were endotoxin free by flow cytometry analysis after treatment with the recombinant forms of the Tp92 homologs.
Sequencing of tp92 homologs. The tp92 homolog of T. denticola (the TDE2601 open reading frame [ORF] of strain ATCC 35405) (46) in the genome sequence of the bacterium was identified using the NCBI BLAST program with the T. pallidum subsp. pallidum tp92 sequence. Nucleotide sequences of the tp92 gene and the T. denticola tp92 homolog were aligned using the program Align from EMBL-EBI, and several degenerate primers were designed for the initial amplification of the tp92 homologs of T. maltophilum and T. socranskii by PCR. In the case of T. lecithinolyticum, a portion of the tp92 homolog (400 bp) was originally identified by screening an expression library for this organism with Abs directed against the T. lecithinolyticum OM fraction. The full sequences of the tp92 homologs of T. lecithinolyticum, T. maltophilum, and T. socranskii were obtained by PCR amplification using the degenerate primers described above or by inverse PCR using specific primers designed from the partial sequences, followed by sequencing using a DNA sequencer (ABI; Applied Biosystems, Foster City, CA).
Primary structure analyses of translated proteins were performed by using ProtParam from ExPASy. Pairwise sequence comparisons were performed using Align from EMBL-EBI to analyze sequence homology. The predictions of protein subcellular localization patterns and signal peptides were analyzed using PSORTb (version 2.0) (20) and SignalP (version 3.0) (6), respectively.
Cloning and expression of tp92 homologs. The tp92 gene homologs of T. denticola, T. lecithinolyticum, T. maltophilum, and T. socranskii were amplified from the genomic DNA by PCR and cloned without the sequences encoding the leader peptides. The sequences of the PCR primers were as follows: 5'-AAC TGA GCT CGG ATG GTA TAA TGG AAA ACC TG-3' (SacI tagged) and 5'-AAC TCT GCA GCT ATA AAT TGG GTA TAT TGA ATG AA-3' (PstI tagged) for T. denticola, 5'-AAC TGA GCT CGA AAG CGA TTG GTA TTA CGG A-3' (SacI tagged) and 5'-AAC TCT GC A GTT ATT GAT TGG TAA GGT TAA AAG-3' (PstI tagged) for T. lecithinolyticum, 5'-AAC TGG ATC CCA AAG CGA CAA TAA CTG GTA-3' (BamHI tagged) and 5'-AAC TGA GCT CTT ATT GAT TGA CCA AAT TG-3' (SacI tagged) for T. maltophilum, and 5'-AAC TGG ATC CGA AGA AAG CGA AGA CGA AGG-3' (BamHI tagged) and 5'-AAC TAA GCT TTT ATC AGC GGT TCG TTA TGT TGA-3' (HindIII tagged) for T. socranskii. The primers were designed to introduce restriction sites (underlined) and an additional four nucleotides to the 5' ends of these restriction sites. PCR was performed in a total volume of 50 µl containing 15 pmol of each primer, 1.25 U of Ex Taq polymerase (Perkin Elmer Cetus, Foster City, CA), and 10 nmol of each deoxynucleoside triphosphate in a thermal cycler (PerkinElmer). The thermal cycle chosen included an initial denaturation step at 94°C for 4 min; 30 cycles of a denaturation step at 94°C for 1 min, an annealing step at 62°C for 1 min, and an extension step at 72°C for 1 min; and a final incubation at 72°C for 5 min. The PCR products were cloned in E. coli by using the TA cloning vector pCR2.1-TOPO, and the inserts were isolated and cloned in E. coli M15 by using the expression vector pQE-30 as described previously (33). After the induction of E. coli with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG), histidine-tagged recombinant proteins were purified by sonication, solubilization with a detergent, and subsequent renaturation, followed by affinity chromatography using nickel-nitrilotriacetic acid agarose (Qiagen, Valencia, CA) as described previously (33).
Endotoxins present in E. coli, which may potentially contaminate the recombinant proteins, were removed using polymyxin B-agarose according to the instructions of the manufacturer (Sigma Chemical Co., St. Louis, MO). The recombinant proteins were concentrated using Centricon YM-30 (Millipore, Bedford, MA), sterile filtered through 0.25-µm-pore-size membrane filters, and quantified using the bicinchoninic acid protein assay kit (Pierce, Rockford, IL).
For the mock extract used as a control for endotoxin contamination in the reagents, E. coli transformed with pQE-30 without the insert DNA was cultured and induced with IPTG. The subsequent procedures and all chemicals used were the same as those used in the preparation of the Tp92 homologs. Irrelevant N-terminally hexahistidine-tagged peptides of T. lecithinolyticum MspTL (33) and PP4 (32) were also prepared using the same procedures.
The Tp92 homologs were named Td92 for T. denticola, Tl88 for T. lecithinolyticum, Tm88 for T. maltophilum, and Tss88 for T. socrnaskii subsp. socranskii, according to their molecular weights.
Verification of endotoxin decontamination of the recombinant proteins.
TLR4-dependent NF-
B activation was analyzed to verify endotoxin decontamination of the recombinant Tp92 homologs by flow cytometry analysis. CHO/CD14/TLR4 cells were cultured to 70% confluence in Ham's F-12 medium and stimulated with the recombinant Tp92 homologs (10 µg/ml) or lipopolysaccharide (LPS; 1 µg/ml) in the presence of 2% FBS for 16 h. The cells were subjected to flow cytometry analysis using fluorescein isothiocyanate (FITC)-labeled mouse anti-human CD25 (Becton Dickinson, San Diego, CA) as described previously (24). FITC-labeled mouse immunoglobulin G1 (IgG1; Becton Dickinson) was used as an isotype-matched control.
Production of antisera against the Tp92 homolog of T. denticola. Polyclonal Abs against the T. denticola Tp92 homolog were raised in New Zealand White rabbits by the intradermal administration of 500-µg doses of the purified proteins with complete Freund's adjuvant (500 µg [catalog no. F5881; Sigma]) followed by three subsequent booster doses of 200 µg of the proteins with incomplete Freund's adjuvant (500 µg [catalog no. F5506; Sigma]) at 2-week intervals. Antisera were collected 1 week after the final booster dose. The antisera were shown to contain high titers of specific Abs against the recombinant T. denticola Tp92 homolog, as judged by enzyme-linked immunosorbent assays (ELISAs) and immunoblotting using horseradish peroxidase (HRP)-labeled mouse anti-rabbit IgG (R&D Systems, Minneapolis, MN). Abs that cross-reacted with E. coli proteins and the histidine tag were removed by affinity chromatography using activated cyanogen bromide-activated Sepharose 4B (Amersham Pharmacia Biotech, Piscataway, NJ) according to standard protocols. For this purpose, E. coli M15 sonicates or an irrelevant histidine-tagged protein, PP4 (32), was coupled to cyanogen bromide-activated Sepharose 4B. The antisera were applied to the Sepharose, and the unbound fractions of the antisera containing the specific Abs were collected. IgG Abs (designated anti-Td92 Ab) were purified using an ImmunoPure (A Plus) IgG purification kit according to the instructions of the manufacturer (Pierce, Rockford, IL). Finally, endotoxin contamination in the IgG fraction was removed using polymyxin B-agarose (Sigma).
Preparation of the OM fraction of T. denticola. The OM of T. denticola was isolated by a combined protocol of freeze-thaw procedures and sucrose density gradient centrifugation with a slight modification (44, 47). Briefly, T. denticola cells (80-ml culture) were harvested and washed with phosphate-buffered saline (PBS) by centrifugation at 8,000 x g for 10 min. The cell pellet was resuspended in 1 ml of 50 mM Tris-HCl buffer (pH 7.2) containing 20 mM MgCl2, 2 mM phenylmethylsulfonyl fluoride, and DNase 1 (4 U/ml). After the cells were subjected to 40 freeze-thaw cycles, the disrupted cell suspension was centrifuged at 8,000 x g for 10 min. The supernatant containing the OM was transferred into a new tube and centrifuged at 25,000 x g for 30 min. The pellet was washed twice with 50 mM Tris-HCl (pH 7.2) and resuspended in 1 ml of 0.1 M sodium acetate buffer (pH 3.0), and the suspension was mixed gently for 2 h to remove contaminating flagella and then subjected to centrifugation at 25,000 x g for 30 min. The pellet was washed with and resuspended in 0.8 ml of 50 mM Tris-HCl buffer, and the suspension was subjected to sucrose gradient centrifugation with 25, 42, and 56% sucrose at 100,000 x g for 16 h at 4°C in an ultracentrifuge (TLA110 rotor; Beckman Instruments Inc., Fullerton, CA). The upper fraction containing the OM was removed and precipitated with methanol and chloroform. The precipitated OM fraction was resuspended in 50 µl of PBS and used to detect Td92 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot analysis.
Immunoblotting. The expression of the Tp92 homologs in E. coli was verified by immunoblotting using a monoclonal mouse antihistidine Ab (Qiagen, Valencia, CA). E. coli M15 cells transformed with the recombinant plasmids were cultured in Luria-Bertani broth containing antibiotics and induced with IPTG. The E. coli lysates (20 µg of protein) were subjected to SDS-PAGE and subsequently transferred onto nitrocellulose membranes. The membranes were blocked with 2% bovine serum albumin (BSA) for 1 h and allowed to react with antihistidine Ab for 1 h. After being washed with PBS-0.2% Tween 20, the membranes were allowed to react with alkaline phosphatase-labeled anti-mouse IgG for 1 h. After being washed with PBS-0.2% Tween 20, the membranes were developed with 5-bromo-4-chloro-3-indolylphosphate (165 µg/ml) and nitroblue tetrazolium (330 µg/ml).
The reactivity of the anti-Td92 Ab was tested using the lysates of T. denticola whole cells, the OM fraction, and the recombinant Td92. Whole-cell lysates of T. denticola, the OM fraction, and Td92 were separated by SDS-PAGE and transferred onto nitrocellulose membranes. The membranes were blocked with PBS-2% BSA and allowed to react with anti-Td92 Ab for 1 h, followed by HRP-labeled goat anti-rabbit IgG for 1 h. After being washed with PBS-0.2% Tween 20, the membranes were developed with 3,3',5,5'-tetramethylbenzidine (TMB; Sigma). To verify the purity of the OM preparation, immunoblotting using rabbit anti-FlaA (1:5,000 dilution; a kind gift from Christopher Fenno), which detects the periplasmic protein FlaA, was performed.
Immunodot blotting. The cross-reactivity of Tp92 homologs with the anti-Td92 Ab was analyzed by immunodot blotting. The recombinant Tp92 homologs (250 ng in 1 µl) were applied onto a nitrocellulose membrane and air dried. The membrane was allowed to react with the anti-Td92 Ab, and the reaction was detected as described above. An irrelevant histidine-tagged recombinant protein, MspTL (30), and E. coli lysates were used as negative controls.
Indirect immunofluorescence microscopy. Treponema species grown to early stationary phase were harvested, resuspended in PBS, and applied to glass slides coated with silane (Sigma). Some of the slides were used directly, and the others were used after fixation with cold acetone for 15 min and subsequent permeabilization of the OMs with 0.1% Triton X-100 in PBS for 5 min. The bacteria were incubated in PBS containing 1% BSA for 1 h and then allowed to react with the anti-Td92 Ab or anti-FlaA Ab (1:1,000 dilution) for 1 h. After being washed three times with PBS, the bacteria were allowed to react with FITC-labeled goat anti-rabbit IgG (1:50 dilution in PBS containing 1% BSA) and washed three times with PBS. To see all the bacteria applied, the slides were further stained with a fluorescent nucleic acid stain, Hoechst dye 33258 (2 µg/ml in PBS; Invitrogen), for 30 min. The cells were washed three times with PBS and observed with a fluorescence microscope (Carl Zeiss, Axioskop, Germany) at a magnification of x1,000. Anti-FlaA Ab (1:500 dilution) was used as a control to verify that the OMs of the bacteria were intact during the immunofluorescence assay. As a control for nonspecific binding, rabbit preimmunization serum was used instead of anti-Td92 Ab.
Flow cytometry analysis. T. denticola cells (5 x 107) were fixed with acetone and permeabilized as described above. Unfixed and acetone-fixed bacteria were allowed to react with the anti-Td92 Ab or the anti-FlaA Ab (1:500 dilution) in 100 µl of PBS containing 1% BSA at room temperature for 1 h. The bacteria were washed twice with PBS containing 0.02% BSA and allowed to react with FITC-labeled goat anti-rabbit IgG (1:50 dilution in 1% BSA in PBS) at room temperature for 1 h. After being washed twice with PBS, the bacteria were analyzed using a fluorescence-activated cell sorter (FACSCalibur; Becton Dickinson, San Jose, CA). The data were obtained by using 40,000 cells. The number of bacteria was determined as described previously (30). Isotype-matched Ab (rabbit IgG) was used as a negative control.
Cell binding assay. To determine whether the Tp92 homologs were able to bind to host cells, the binding assay was performed using KB cells, an oral carcinoma epithelial cell line, and FITC-labeled Tp92 homologs. KB cells (105 cells/500 µl) were cultured in 24-well culture plates to confluence. After a change to serum-free medium, the FITC-labeled Tp92 homologs were added to the cells (at 2.5 µg per well) and the plates were incubated at 37°C under 5% CO2 for 1 h. The cells were detached from the cell culture plates by using 200 µl of 1x trypsin-EDTA, washed with serum-containing medium, and subsequently washed three times with PBS by centrifugation at 100 x g. The fluorescence of the cells was then measured by a fluorometer (FLUOStar+ OPTIMA; BMG Labtechnologies Inc., Durham, NC). The level of protein binding was expressed as the percentage of bound proteins relative to the total proteins added by using the following formula: (bound fluorescence)/(total fluorescence added) x 100. One microgram of Td92 was equivalent to 109 cells of T. denticola, as judged by SDS-PAGE and subsequently by the immunoblotting of aliquots containing various numbers of bacteria. The number of T. denticola cells (optical density at 600 nm [OD600] = 0.2) corresponded to a concentration of 5 x 109 cells/ml, as determined using a Petroff-Hausser counting chamber (Hausser Scientific, Hosham, PA).
To confirm that the Tp92 homologs function as adhesins, the inhibition of the binding of fluorescence-labeled T. denticola cells to epithelial cells by Td92 was tested. T. denticola cells were grown to early stationary phase, harvested, and resuspended in PBS, and the suspension was adjusted to an OD600 of 1.0. Aliquots (1 ml) of bacteria were centrifuged and resuspended in 1 ml of PBS. The bacteria were stained with 10 µM carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes, Eugene, OR) for 10 min at room temperature and washed three times with PBS, followed by storage at –20°C for 24 h to induce fluorescence stabilization. CFSE-labeled bacteria were diluted with PBS to an OD600 of 0.2 (5 x 109 bacteria/ml). KB cells were cultured in 24-well culture plates (105 cells/500 µl) to confluence, washed twice with serum-free medium, and incubated with CFSE-labeled bacteria (100 µl) in the presence of Td92 (1 to 10 µg) at 37°C under 5% CO2 for 1 h. The cells were detached and washed three times with PBS by centrifugation at 100 x g, and the fluorescence of the adherent bacteria was determined using a fluorometer as described above. An irrelevant histidine-tagged recombinant protein (PP4) was used as a negative control. The ratio of T. denticola cells to KB cells used for the binding competition assay was 5,000:1.
Cell culture and treatment with Tp92 homologs. Human monocytic THP-1 cells (1 x 106 cells/ml) and primary cultured PDL cells (5 x 105 cells/ml) were cultured as described above and plated into 35-mm culture dishes in the absence of serum. The cells were then treated with 10-µg/ml concentrations of each of the recombinant Tp92 homologs for 12 to 24 h. The cells were harvested and used for RNA isolation, and the conditioned supernatants were collected and stored at –70°C for the gelatin zymography and ELISA. Cells treated with E. coli LPS (10 µg/ml) were used as a positive control, and untreated or mock extract-treated cells were used as a negative control.
Real-time RT-PCR.
RNA from the THP-1 cells and PDL cells treated with the Tp92 homologs was prepared using an easy-BLUE total extraction kit (iNtRON Biotechnology, South Korea), and cDNA was synthesized from 1 µg of RNA by using a Maxime reverse transcriptase (RT) premix kit according to the protocols of the manufacturer (iNtRON Biotechnology, South Korea). For real-time PCR, cDNA (1 µl) was mixed with 10 µl of Sybr premix Ex Taq (Takara Bio Inc., Japan) and primer pairs (4 pmol each) in a 20-µl reaction volume, and the mixture was subjected to PCR for 40 cycles of a denaturation step at 95°C for 15 s, an annealing step at 60°C for 15 s, and an extension step at 72°C for 33 s in an ABI PRISM 7500 fast real-time PCR system (Applied Biosystems, Foster City, CA). The PCR products were subjected to a melting-curve analysis to verify the presence of a single amplification product. PCR without RT was performed as a negative control. The housekeeping gene encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a reference in order to normalize expression levels and to quantify changes in gene expression levels between untreated controls and Tp92 homolog-treated cells. The change (n-fold) in the expression level of each gene was determined from the difference in cycle numbers to reach a threshold value between the values for control and Tp92 homolog-treated cells and was expressed as a log2 ratio. The sequences of the primers for real-time RT-PCR were as follows: 5'-AGC TGT ACC CAG AGA GTC C-3' and 5'-ACC AAA TGT GGC CGT GGT TT-3' for the IL-1β gene, 5'-AAC CTG TCC ACT GGG CAC A-3' and 5'-TCT GGC TCT GAA ACA AAG GAT-3' for the IL-6 gene, 5'-GTG AAG GTG CAG TTT TGC CA-3' and 5'-TCT CCA CAA CCC TCT GCA C-3' for the IL-8 gene, 5'-CAG GGA CCT CTC TCT AAT CA-3' and 5'-AGC TGG TTA TCT CTC AGC TC-3' for the TNF-
gene, 5'-CTC TGG AGG TTC GAC GTG A-3' and 5'-CTG CAG GAT GTC ATA GGT CA-3' for the matrix metalloproteinase 9 (MMP-9) gene, 5'-AAG CTG GGA AGC CTT CTC TA-3' and 5'-GTG CTG GGC AAA GAA TGC AA-3' for the cyclooxygenase 2 (COX-2) gene, and 5'-GTG GTG GAC CTG ACC TGC-3' and 5'-TGA GCT TGA CAA AGT GGT CG-3' for the GAPDH gene.
ELISAs for cytokines and PGE2.
The culture supernatants of the cells treated with Tp92 homologs were assayed to determine IL-1β, TNF-
, IL-6, IL-8, and PGE2 levels by using the ELISA kits from R&D Systems (Minneapolis, MN).
Gelatin zymography. To detect MMP-9 expression, a gelatin zymography analysis of the culture supernatants (25 µl) of THP-1 cells treated with the Td92 homologs was performed as described previously (9). Culture supernatants of THP-1 cells treated with 10 µg of E. coli LPS were used as positive controls. Culture supernatants of untreated cells or mock extract-treated cells were used as negative controls. To confirm that the gelatinolytic activity was based on MMP-9, but not on other proteases, the gels were incubated in reaction buffer containing 2 mM EDTA, an MMP inhibitor, after SDS-PAGE.
Statistical analyses. Statistically significant differences between the untreated and recombinant Tp92 homolog-treated cells were evaluated using Student's t test. A P value of <0.05 was considered significant.
Nucleotide sequence accession numbers. DNA sequences of the tp92 gene homologs have been submitted to the GenBank database under accession no. EU057146 for tl88 of T. lecithinolyticum, EU057147 for tss88 of T. socranskii subsp. socranskii, and EU057148 for tm88 of T. maltophilum.
| RESULTS |
|---|
|
|
|---|
The translated amino acid sequences corresponding to the tp92 homologs in the oral treponemes revealed significant homology to the amino acid sequence of T. pallidum Tp92. The Tp92 homologs of four oral treponemes showed amino acid sequence identities of 37.9 to 49.3% and similarities of 54.5 to 66.9% to Tp92 (Table 1). The sequence identities and similarities of the oral treponeme homologs to one another were 41.6 to 71.6% and 59.9 to 85.6%, respectively. The Tp92 homologs showed sequence identities of 28.4 to 30.2% and 22.2 to 23.7% and similarities of 46.9 to 49.7% and 37.0 to 39.4% to homologs from two nonoral spirochetes, B. burgdorferi B31 and L. interrogans serovar Copenhageni, respectively.
|
Cloning and expression of the tp92 gene homologs in E. coli. The tp92 gene homologs were successfully expressed in E. coli by using the pQE-30 vector after PCR and TA cloning (Fig. 1). As expected from the deduced amino acid sequences, the molecular sizes of the recombinant Tp92 homologs were approximately 92 kDa for the T. denticola homolog and 88 kDa for the T. lecithinolyticum, T. maltophilum, and T. socranskii subsp. socranskii homologs. The recombinant proteins formed in the inclusion bodies were purified by solubilization, renaturation, and affinity chromatography using nickel-nitrilotriacetic acid agarose. These proteins were employed in the study for host cell stimulation after further purification through the removal of any possible E. coli LPS contamination by using polymyxin B-agarose.
|
|
|
|
|
|
|
B activation. The Tp92 homologs did not increase CD25 expression in the cells, whereas LPS significantly increased the expression of CD25 (data not shown).
Using THP-1 and PDL cells, we analyzed the regulation of representative proinflammatory and osteoclastogenic factors that are known to stimulate RANKL, which is involved in osteoclastogenesis leading to bone resorption. Monocytes are among the early immune cells that react to the local presence of bacteria, and PDL is a supporting tissue linking the root surface and alveolar bone. As shown in Fig. 8, the addition of the Tp92 homologs at the concentration of 10 µg/ml significantly upregulated IL-1β, TNF-
, IL-6, and IL-8 at both the gene and protein levels in THP-1 cells as analyzed by real-time RT-PCR and ELISAs, respectively. In PDL cells, IL-6 and IL-8 were upregulated by Tp92 homologs (Fig. 8). A dose dependence analysis showed that Td92 at the concentration of 1 µg/ml significantly induced IL-8 mRNA (data not shown). The expression of COX-2 and its product, PGE2, in both THP-1 and PDL cells was also induced by the Tp92 homologs (Fig. 9). In a gelatin zymography analysis, the Tp92 homologs induced gelatinolytic activity corresponding to a molecular mass of 92 kDa, attributed to MMP-9, in THP-1 cells (Fig. 10). This gelatinolytic activity was inhibited by 2 mM EDTA, an MMP inhibitor (data not shown). The Tp92 homologs themselves showed no gelatinolytic activity.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
In spite of high levels of homology to Tp92, the Tp92 homologs of oral spirochetes have distinct characteristics. First, the Tp92 homologs of oral spirochetes have no serine-rich region at the C terminus, which is a signature sequence in the T. pallidum Tp92. The C terminus of Tp92 encompassing the serine repeat signature sequence (245 aa) was not expressed in E. coli. However, the full-length tp92 gene homologs of oral spirochetes were expressed in E. coli, showing products with expected molecular masses. Second, the calculated pIs of the Tp92 homologs were different from that of Tp92. The pIs of the Tp92 homologs were in the acidic range between 5.46 and 6.34, while the pI of Tp92 is 8.27. Third, a cysteine residue is absent in the Tp92 homologs of oral spirochetes, and only one is present in the case of T. lecithinolyticum and T. maltophilum, while three cysteine residues are present in Tp92, implying possible intradisulfide bond formation. It will be interesting to examine whether these differences are linked to distinct functions.
T. denticola, along with Porphyromonas gingivalis and Tannerella forsythensis ("Tannerella forsythia"), belongs to the red cluster according to the classification by Socransky et al. (48), who defined bacterial groups in dental plaque biofilm with respect to their reciprocal associations and sequential formation. The red complex produces significant amounts of proteases, including trypsinlike peptidase activity, and is in contact with the gingival junctional epithelium. In this study, we observed that the Tp92 homologs adhered to epithelial cells, suggesting that the encoded proteins mediate the binding of Treponema cells to host cells and thus accelerate the pathological effects of the bacteria. Several surface proteins of T. denticola have been reported previously to attach to host cells or extracellular matrix proteins. The best studied is the 53-kDa Msp, which is able to bind epithelial cells and fibroblasts and extracellular matrix proteins like fibronectin, keratin, laminin, collagen, fibrinogen, hyaluronic acid, and heparin (14, 15). Chymotrypsinlike protease has been demonstrated previously to bind to PDL epithelial cells (18) and to P. gingivalis fimbriae, implicating it in the coaggregation of T. denticola and P. gingivalis (25). The leucine-rich-repeat protein LrrA has been demonstrated previously to attach to human epithelial cells (29). OppA (70 kDa) binds soluble plasminogen and fibronectin (19). In the present study, Td92 significantly inhibited T. denticola adhesion to epithelial cells, although not completely. This fact suggests that Td92 is one of the T. denticola adhesins.
The Tp92 homologs upregulated IL-1β, TNF-
, IL-6, IL-8, PGE2, and MMP-9 in THP-1 cells. These factors are proinflammatory and osteoclastogenic factors and have been reported previously to be stimulated by periodontopathogens, including the members of the red complex. IL-1β and TNF-
are representative proinflammatory cytokines associated with periodontal disease characterized by a loss of connective tissue attachment and bone resorption leading to alveolar bone loss (22). IL-1β is a potent stimulator of bone resorption and an inhibitor of bone formation that enhances osteoclast differentiation and acts as a survival factor for mature osteoclasts (26, 31, 54). It has been shown previously to activate RANKL in PDL cells (40). TNF-
promotes the production of RANKL and macrophage colony-stimulating factor by stromal cells and induces osteoclast formation. In experimental periodontitis, IL-1 and TNF antagonists have been demonstrated previously to inhibit the inflammatory response and bone loss (22). IL-6, together with IL-1β and TNF-
, is a major mediator of the host response to tissue destruction and bone resorption. IL-6 binds to its receptor, existing in either a membrane-bound form (CD126) or a soluble form (soluble IL-6 receptor alpha). This complex subsequently binds to a signal-transducing protein, gp130 (42), leading to the upregulation of RANKL in osteoblasts, which is a key factor in osteoclastogenesis. IL-8 is a representative chemokine and leads inflammatory cells to infection sites, playing an important role in initiating the inflammatory reactions. PGE2 stimulates osteoclastogenesis through the stimulation of RANKL production, the inhibition of osteoprotegerin secretion by osteoblasts, and the stimulation of IL-6 production (11, 35). PGE2 is synergistically stimulated by IL-1 and TNF in human gingival fibroblasts (56). MMP-9 is a zinc-dependent proteinase and has been demonstrated previously to play an important role in the bone resorption process by dissolving the bone matrix, releasing the chemotactic factor on osteoclasts, and activating the cytokines involved in bone resorption (17). Although various periodontopathogens have been shown previously to induce all these host factors, only a few bacterial factors have been identified at the molecular level. LPS is a prominent molecule that induces proinflammatory cytokines and bone-resorbing factors. LPS or LPS-like molecules of periodontopathogens have been demonstrated previously to modulate biological activities, including the upregulation of IL-1, TNF-
, IL-6, IL-8, PGE2, and MMP-9, in various host cell types (4, 10, 23, 39). These factors are found at significantly higher levels in the tissues and gingival crevicular fluids of periodontitis patients than in those of healthy subjects (52, 57). Among surface proteins, the OMP 100 of Aggregatibacter (Actinobacillus) actinomycetemcomitans and fimbrillin of P. gingivalis (41 and 67 kDa) have been demonstrated previously to induce proinflammatory cytokines in host cells, including epithelial cells and macrophages (3, 27, 41). The 67-kDa P. gingivalis fimbria protein induces osteoclast differentiation, and the blocking of IL-1, TNF, and IL-6 induced by the protein reduces osteoclast differentiation. Recently, we reported that the major surface protein MspTL of T. lecithinolyticum induces IL-1β, TNF-
, IL-6, and PGE2 in THP-1 cells (32, 33). Although the Tp92 homologs are not abundant surface proteins like Msp of T. denticola and MspTL of T. lecithinolyticum, as judged by SDS-PAGE profiles, they are widely distributed in oral spirochetes, and the coexistence of various species of oral spirochetes in a single patient or site may result in the amplification of the cytopathological effects on host cells.
In summary, Tp92 homologs are surface-exposed OMPs that are common among the four oral Treponema species strongly associated with periodontitis. Using the recombinant forms of the Tp92 homologs that were expressed in E. coli, we have shown that these proteins have the potential to bind to host cells and stimulate host factors that contribute to inflammation and osteoclastogenesis, which are major characteristics of periodontitis. The roles of these common antigens as protective immunogens against periodontitis will be studied in the future.
| ACKNOWLEDGMENTS |
|---|
This work was supported by a Korea Research Foundation grant (KRF-2003-205-E00033) funded by the Korean government (MOEHRD, Basic Research Promotion Fund). H.-K. Jun, H.-R. Lee, and S.-H. Lee are recipients of a scholarship from the BK21 program (Craniomaxillofacial Life Science 21).
| FOOTNOTES |
|---|
Published ahead of print on 7 April 2008. ![]()
| REFERENCES |
|---|
|
|
|---|
| 1. | Adler, B., D. Bulach, J. Chung, S. Doughty, M. Hunt, K. Rajakumar, M. Serrano, A. van Zanden, Y. Zhang, and C. Ruffolo. 1999. Candidate vaccine antigens and genes in Pasteurella multocida. J. Biotechnol. 73:83-90.[CrossRef][Medline] |
| 2. | Armitage, G. C., W. R. Dickinson, R. S. Jenderseck, S. M. Levine, and D. W. Chambers. 1982. Relationship between the percentage of subgingival spirochetes and the severity of periodontal disease. J. Periodontol. 53:550-556.[Medline] |
| 3. | Asakawa, R., H. Komatsuzawa, T. Kawai, S. Yamada, R. B. Goncalves, S. Izumi, T. Fujiwara, Y. Nakano, N. Suzuki, Y. Uchida, K. Ouhara, H. Shiba, M. A. Taubman, H. Kurihara, and M. Sugai. 2003. Outer membrane protein 100, a versatile virulence factor of Actinobacillus actinomycetemcomitans. Mol. Microbiol. 50:1125-1139.[CrossRef][Medline] |
| 4. | Baqui, A. A., T. F. Meiller, J. J. Chon, B. F. Turng, and W. A. Falkler, Jr. 1998. Granulocyte-macrophage colony-stimulating factor amplification of interleukin-1β and tumor necrosis factor alpha production in THP-1 human monocytic cells stimulated with lipopolysaccharide of oral microorganisms. Clin. Diagn. Lab. Immunol. 5:341-347.[Medline] |
| 5. | Batista Da Silva, A. P., W. Lee, E. Bajenova, C. A. McCulloch, and R. P. Ellen. 2004. The major outer sheath protein of Treponema denticola inhibits the binding step of collagen phagocytosis in fibroblasts. Cell. Microbiol. 6:485-498.[CrossRef][Medline] |
| 6. | Bendtsen, J. D., H. Nielsen, G. von Heijne, and S. Brunak. 2004. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340:783-795.[CrossRef][Medline] |
| 7. | Cameron, C. E., S. A. Lukehart, C. Castro, B. Molini, C. Godornes, and W. C. Van Voorhis. 2000. Opsonic potential, protective capacity, and sequence conservation of the Treponema pallidum subspecies pallidum Tp92. J. Infect. Dis. 181:1401-1413.[CrossRef][Medline] |
| 8. | Chan, E. C., and R. McLaughlin. 2000. Taxonomy and virulence of oral spirochetes. Oral Microbiol. Immunol. 15:1-9.[CrossRef][Medline] |
| 9. | Choi, B. K., J. H. Jung, H. Y. Suh, Y. J. Yoo, K. S. Cho, J. K. Chai, and C. K. Kim. 2001. Activation of matrix metalloproteinase-2 by a novel oral spirochetal species Treponema lecithinolyticum. J. Periodontol. 72:1594-1600.[CrossRef][Medline] |
| 10. | Choi, B. K., H. J. Lee, J. H. Kang, G. J. Jeong, C. K. Min, and Y. J. Yoo. 2003. Induction of osteoclastogenesis and matrix metalloproteinase expression by the lipooligosaccharide of Treponema denticola. Infect. Immun. 71:226-233. |
| 11. | Choi, B. K., S. Y. Moon, J. H. Cha, K. W. Kim, and Y. J. Yoo. 2005. Prostaglandin E2 is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii. J. Periodontol. 76:813-820.[CrossRef][Medline] |
| 12. | Dewhirst, F. E., M. A. Tamer, R. E. Ericson, C. N Lau, V. A. Levanos, S. K. Boches, J. L. Galvin, and B. J. Paster. 2000. The diversity of periodontal spirochetes by 16S rRNA analysis. Oral Microbiol. Immunol. 15:196-202.[CrossRef][Medline] |
| 13. | Duncan, M. J. 2005. Oral microbiology and genomics. Periodontology 2000 38:63-71.[CrossRef][Medline] |
| 14. | Edwards, A. M., H. F. Jenkinson, M. J. Woodward, and D. Dymock. 2005. Binding properties and adhesion-mediating regions of the major sheath protein of Treponema denticola ATCC 35405. Infect. Immun. 73:2891-2898. |
| 15. | Ellen, R. P. 2002. Adhesion of oral spirochaetes to host cells and its cytopathogenic consequences, p. 247-276. In M. Wilson (ed.), Bacterial adhesion to host tissues: mechanisms and consequences. Cambridge University Press, Cambridge, United Kingdom. |
| 16. | Ellen, R. P., and V. B. Galimanas. 2005. Spirochetes at the forefront of periodontal infections. Periodontology 2000 38:13-32.[CrossRef][Medline] |
| 17. | Engsig, M. T., Q.-J. Chen, T. H. Vu, A.-C. Pedersen, B. Therkidsen, L. R. Lund, K. Henriksen, T. Lenhard, N. T. Foged, Z. Werb, and J.-M. Delaissé. 2000. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151:879-889. |
| 18. | Fenno, J. C., P. M. Hannam, W. K. Leung, M. Tamura, V. J. Uitto, and B. C. McBride. 1998. Cytopathic effects of the major surface protein and the chymotrypsinlike protease of Treponema denticola. Infect. Immun. 66:1869-1877. |
| 19. | Fenno, J. C., M. Tamura, P. M. Hannam, G. W. Wong, R. A. Chan, and B. C. McBride. 2000. Identification of a Treponema denticola OppA homologue that binds host proteins present in the subgingival environment. Infect. Immun. 68:1884-1892. |
| 20. | Gardy, J. L., M. R. Laird, F. Chen, S. Rey, C. J. Walsh, M. Ester, and F. S. L. Brinkman. 2005. PSORTb v. 2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 21:617-623. |
| 21. | Genevrois, S., L. Steeghs, P. Roholl, J. J. Letesson, and P. van der Ley. 2003. The Omp85 protein of Neisseria meningitidis is required for lipid export to the outer membrane. EMBO J. 22:1780-1789.[CrossRef][Medline] |
| 22. | Graves, D. T., and D. Cochran. 2003. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J. Periodontol. 74:391-401.[CrossRef][Medline] |
| 23. | Grenier, D., and L. Grignon. 2006. Response of human macrophage-like cells to stimulation by Fusobacterium nucleatum ssp. nucleatum lipopolysaccharide. Oral Microbiol. Immunol. 21:190-196.[CrossRef][Medline] |
| 24. | Han, S. H., J. H. Kim, M. Martin, S. M. Michalek, and M. H. Nahm. 2003. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect. Immun. 71:5541-5548. |
| 25. | Hashimoto, M., S. Ogawa, Y. Asai, Y. Takai, and T. Ogawa. 2003. Binding of Porphyromonas gingivalis fimbriae to Treponema denticola dentilisin. FEMS Microbiol. Lett. 226:267-271.[CrossRef][Medline] |
| 26. | Haynes, D., G. J. Atkins, M. Loric, T. N. Crotti, S. M. Geary, and D. M. Findlay. 1999. Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation. Bone 25:269-278.[Medline] |
| 27. | Hiramine, H., K. Watanabe, N. Hamada, and T. Umemoto. 2003. Porphyromonas gingivalis 67-kDa fimbriae induced cytokine production and osteoclast differentiation utilizing TLR2. FEMS Microbiol. Lett. 229:49-55.[CrossRef][Medline] |
| 28. | Horwood, N. J., J. Elliott, T. J. Martin, and M. T. Gillespie. 1998. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:4743-4746. |
| 29. | Ikegami, A., K. Honma, A. Sharma, and H. K. Kuramitsu. 2004. Multiple functions of the leucine-rich repeat protein LrrA of Treponema denticola. Infect. Immun. 72:4619-4627. |
| 30. | Ji, S., J. Hyun, E. Park, B.-L. Lee, K.-K. Kim, and Y. Choi. 2007. Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J. Periodontal Res. 42:410-419.[CrossRef][Medline] |
| 31. | Jimi, E., I. Nakamura, L. T. Doung, T. Ikebe, N. Takahashi, G. A. Rodan, and T. Suda. 1999. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp. Cell Res. 247:84-93.[CrossRef][Medline] |
| 32. | Jun, H. K., H. R. Lee, S. H. Lee, and B. K. Choi. 2007. Mapping of the proinflammatory domains of MspTL of Treponema lecithinolyticum. Microbiology 153:2386-2392. |
| 33. | Lee, S. H., K. K. Kim, and B. K. Choi. 2005. Upregulation of intercellular adhesion molecule 1 and proinflammatory cytokines by the major surface proteins of Treponema maltophilum and Treponema lecithinolyticum, the phylogenetic group IV oral spirochetes associated with periodontitis and endodontic infections. Infect. Immun. 73:268-276. |
| 34. | Lembariti, B. S., F. H. Mikx, and W. H. van Palenstein Helderman. 1995. Microscopic spirochete counts in untreated subjects with and without periodontal tissue destruction. J. Clin. Periodontol. 22:235-239.[Medline] |
| 35. | Liu, X. H., A. Kirschenbaum, S. Yao, and A. C. Levine. 2006. Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system. Ann. N. Y. Acad. Sci. 1068:225-233. |
| 36. | Loosmore, S. M., Y. P. Yang, D. C. Coleman, J. M. Shortreed, D. M. England, and M. H. Klein. 1997. Outer membrane protein D15 is conserved among Haemophilus influenzae species and may represent a universal protective antigen against invasive disease. Infect. Immun. 65:3701-3707.[Abstract] |
| 37. | Mathers, D. A., W. K. Leung, J. C. Fenno, Y. Hong, and B. C. McBride. 1996. The major surface protein complex of Treponema denticola depolarizes and induces ion channels in HeLa cell membranes. Infect. Immun. 64:2904-2910.[Abstract] |
| 38. | Moter, A., B. Riep, V. Haban, K. Heuner, G. Siebert, M. Berning, C. Wyss, B. Ehmke, T. F. Flemmig, and U. B Göbel. 2006. Molecular epidemiology of oral treponemes in patients with periodontitis and in periodontitis-resistant subjects. J. Clin. Microbiol. 44:3078-3085. |
| 39. | Nakamura, T., H. Nitta, and I. Ishikawa. 2004. Effect of low dose Actinobacillus actinomycetemcomitans lipopolysaccharide pretreatment on cytokine production by human whole blood. J. Periodontal Res. 39:129-135.[CrossRef][Medline] |
| 40. | Nukaga, J., M. Kobayashi, T. Shinki, H. Song, T. Takada, T. Takiguchi, R. Kamijo, and K. Hasegawa. 2004. Regulatory effects of interleukin-1beta and prostaglandin E2 on expression of receptor activator of nuclear factor-kappaB ligand in human periodontal ligament cells. J. Periodontol. 75:249-259.[CrossRef][Medline] |
| 41. | Ouhara, K., H. Komatsuzawa, H. Shiba, Y. Uchida, T. Kawai, K. Sayama, K. Hashimoto, M. A. Taubman, H. Kurihara, and M. Sugai. 2006. Actinobacillus actinomycetemcomitans outer membrane protein 100 triggers innate immunity and production of beta-defensin and the 18-kilodalton cationic antimicrobial protein through the fibronectin-integrin pathway in human gingival epithelial cells. Infect. Immun. 74:5211-5220. |
| 42. | Palmqvist, P., E. Persson, H. H. Conaway, and U. H. Lerner. 2002. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J. Immunol. 169:3353-3362. |
| 43. | Reumann, S., J. Davila-Aponte, and K. Keegstra. 1999. The evolutionary origin of the protein-translocating channel of chloroplastic envelope membranes: identification of a cyanobacterial homolog. Proc. Natl. Acad. Sci. USA 96:784-789. |
| 44. | Rosen, G., R. Naor, K. Shirley, and M. N. Sela. 1994. Characterization of fibrinolytic activities of Treponema denticola. Infect. Immun. 62:1749-1754. |
| 45. | Sela, M. N. 2001. Role of Treponema denticola in periodontal diseases. Crit. Rev. Oral Biol. Med. 12:399-413. |
| 46. | Seshadri, R., G. S. Myers, H. Tettelin, J. A. Eisen, J. F. Heidelberg, R. J. Dodson, T. M. Davidsen, R. T. DeBoy, D. E. Fouts, D. H. Haft, J. Selengut, Q. Ren, L. M. Brinkac, R. Madupu, J. Kolonay, S. A. Durkin, S. C. Daugherty, J. Shetty, A. Shvartsbeyn, E. Gebregeorgis, K. Geer, G. Tsegaye, J. Malek, B. Ayodeji, S. Shatsman, M. P. McLeod, D. Smajs, J. K. Howell, S. Pal, A. Amin, P. Vashisth, T. Z. McNeill, Q. Xiang, E. Sodergren, E |